HIV transmission at 28 weeks among those whose diagnostic testing was negative at 2 weeks after birth · HIV‐infected mothers and their breastfeeding infants
An extended antiretroviral regimen administered to mothers for 28… showed no clear difference in HIV transmission at 28 weeks among those whose diagnostic testing… compared with an extended NVP regimen administered to infants (moderate certainty).
1 finding from 1 review
Infant mortality at 28 weeks among those whose diagnostic testing was negative at 2 weeks after birth · HIV‐infected mothers and their breastfeeding infants
An extended antiretroviral regimen administered to mothers for 28… showed no clear difference in infant mortality at 28 weeks among those whose diagnostic testing… compared with an extended NVP regimen administered to infants (moderate certainty).
1 finding from 1 review
HIV transmission or death at 28 weeks among those whose diagnostic test was negative at 2 weeks · HIV‐infected mothers and their breastfeeding infants
An extended antiretroviral regimen administered to mothers for 28… showed no clear difference in HIV transmission or death at 28 weeks among those whose diagnostic… compared with an extended NVP regimen administered to infants (moderate certainty).
1 finding from 1 review
Infants with Severe Adverse Events · HIV‐infected mothers and their breastfeeding infants
An extended antiretroviral regimen administered to mothers for 28… showed no clear difference in infants with Severe Adverse Events compared with an extended NVP regimen administered to infants (low certainty).
1 finding from 1 review
Mothers with Severe Adverse Events · HIV‐infected mothers and their breastfeeding infants
An extended antiretroviral regimen administered to mothers for 28… may leads to higher mothers with Severe Adverse Events compared with an extended NVP regimen administered to infants (low certainty).
1 finding from 1 review
Infants with Probably Related Severe Adverse Events · Breastfeeding infants of HIV‐infected mothers
It is very uncertain whether an extended NVP regimen administered to infants for 14 weeks changes infants with Probably Related Severe Adverse Events11 compared with sdNVP plus ZDV (1week) (very low certainty).
1 finding from 1 review
HIV Transmission at 9 months among those whose HIV diagnostic testing was negative within 48 hours of birth · Breastfeeding infants of HIV‐infected mothers
An extended NVP plus ZDV regimen administered to infants for 14 weeks probably leads to lower HIV Transmission at 9 months among those whose HIV diagnostic… compared with sdNVP plus ZDV (1 week) (moderate certainty).
1 finding from 1 review
Percentage of time crying · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Neonatal Infant Pain Scale (NIPS) · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Neonatal Facial Coding Score (NFCS) at 3 minutes (Supplemental breast milk versus control) · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Douleur Aigue du Nouveau‐né (DAN) scale · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Any adverse outcome · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Heart rate · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Duration of crying (seconds) · term newborns (≥ 37 completed weeks' postmenstrual age) and preterm infants (< 37 completed weeks' postmenstrual age) up to maximum of 44…
1 finding from 1 review
Neonatal infection · 176 healthy mother‐infant dyads after normal spontaneous vaginal delivery (rooming‐in: 132, separate care: 44)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal death · nipple stimulation (suckling) for preventing postpartum haemorrhage in the third stage of labour.
It is very uncertain whether summary of findings ‐ Nipple stimulation (suckling) changes maternal death compared with no treatment (comparison 1) (very low certainty).
1 finding from 1 review
Frequency of PPH ≥ 500 mL · nipple stimulation (suckling) for preventing postpartum haemorrhage in the third stage of labour.
Summary of findings ‐ Nipple stimulation (suckling) showed no clear difference in frequency of PPH ≥ 500 mL compared with no treatment (comparison 1) (moderate certainty).
1 finding from 1 review
Amount of blood loss · nipple stimulation (suckling) for preventing postpartum haemorrhage in the third stage of labour.
1 finding from 1 review
Retained placenta · nipple stimulation (suckling) for preventing postpartum haemorrhage in the third stage of labour.
It is very uncertain whether summary of findings ‐ Nipple stimulation (suckling) changes retained placenta compared with no treatment (comparison 1) (very low certainty).
1 finding from 1 review
Perinatal mortality · nipple stimulation (suckling) for preventing postpartum haemorrhage in the third stage of labour.
Summary of findings ‐ Nipple stimulation (suckling) showed no clear difference in perinatal death compared with no treatment (comparison 1) (low certainty).
1 finding from 1 review